Introduction
The membrane-associated adapters of the caveolin family (caveolin1-3) are 22-kDa palmitoylated proteins that associate to the inner leaflet of the plasma membrane and to intracellular vesicular structures. Caveolin proteins can multimerize, and these multimers are required for the formation of caveolae, flask-shaped invaginations of the plasma-membrane and hallmarks of caveolin expression. Caveolin-1 (Cav1) is a cholesterol-binding protein, and cholesterol is required for the formation of caveolae. Cholesterol is key to the organization of signaling platforms within the membrane, and, as a result, Cav1 contributes to cell signaling through its control of the formation and internalization of such membrane-integral signaling centers. In addition, Cav1 associates, via its so-called 'caveolin scaffolding domain' (CSD, aa 82-101) to a large number of signalling proteins, such as integrins, filamins, src-53 family kinases and small GTPases, regulating their membrane targeting and function. [1] [2] [3] [4] Caveolin proteins are differentially expressed in various cell types and tissues, and their expression is in part interdependent: for example, expression of Cav2 requires the presence of Cav1, as result of the stabilization in heteromultimers. 5, 6 Compared to healthy tissue, Cav1 expression is altered in various types of tumor cell and tissue. Cav1 expression is increased in bladder and prostate carcinomas but down-regulated in ovarian, lung and mammary carcinomas. 7 In addition, sporadic mutation (P132L) of Cav1 has also been described, and this mutant version acts in a dominant negative fashion, interfering with the normal functions of Cav1. Cav1 can be phosphorylated on Ser80, converting Cav1 in a secreted protein, which may result in a loss of its (tumor supressor) function within the cell. 7 In general, Cav1 serves as a negative regulator of cell signalling, inhibiting proliferation as well as cell polarity and migration. The molecular mechanisms of these inhibitory effects are only partially resolved, but Cav1 regulation of integrin function is an important aspect of the role for Cav1 in cell motility. In this 'Point-ofView' we will discuss recent insights in the role of Cav1 in integrin-mediated cell adhesion and incorporate some of our own recent findings on this topic.
In migrating cells, most of the Cav1 protein localizes to the rear of the cell. 4, [8] [9] [10] This polarized distribution is mediated by a motif in the Cav1 N-terminus (   46   TKEIDLVNRD   55 ), but it is as yet unknown what this motif binds to. 9, 11 Using live-cell imaging of GFP-Cav1, we have has recently shown that Cav1 travels from the front of polarized cells towards the cell center and accumulates at the rear, which may explain the localization of the protein. 4 This finding shows that a fraction of the total cellular pool of Cav1 transiently targets to the cells' leading edge, which is in agreement with its proposed function in cell adhesion and migration (see below).
Cav1 is involved in the internalization of different types of surface proteins, including ion channels, cytokine-and growth factor receptors and integrins. In line with this notion, Cav1 was found to associate to beta1-integrins and to link beta1-integrins to tyrosine kinases of the Src family, such as Fyn1. Src family kinases regulate, in conjunction with Focal Adhesion Kinase (FAK), FA turnover, migration and proliferation. 15, 16 Cav1 can be phosphorylated on Tyr14 by Src kinases, and the role of this event has been extensively studied in several recent papers. 3, 20 Tyrosine phosphorylation of Cav1 was initially claimed to target the protein to FAs. However, these data were questioned, as it was shown that the phospho-specific Cav1 antibody cross-reacts with phosphorylated paxillin, a FA-resident protein. 21 Yet, there appears to be a role for the Cav1 Tyr14 phosphorylation in the regulation of FAs. Goetz et al. showed, using a Y14F mutant of GFP-Cav1, that tyrosine-phosphorylation of Cav1 is required to stabilize the localization of FAK within FAs. 22 FAK can than recruit additional regulators, such as p130Cas and paxillin, that promote FA turnover, which is important for increased motility. 15 This molecular pathway may constitute a positive feed-back loop, as phosphorylated Cav1 in tumor cells was shown to promote the activity of the small GTPase RhoA, and the RhoA effector ROCK and Src kinase were subsequently implicated in FA turnover and cell migration. 15, 23 In a related study, Grande-Garcia et al used Cav1-/-murine embryonic fibroblasts (MEFs) to show that the absence of Cav1 induces a loss of cell polarity and reduced cell migration. 24 This was accompanied by an increase in Rac1 activity and a loss of RhoA activity, suggesting that Cav1 promotes RhoA signaling, in line with the data from Joshi et al. 23, 24 In the Cav1-/-MEFs, Src activity was increased, and this was found to be required for the loss of polarity in these cells. Src inactivates p190RhoGAP, and this may therefore explain the reduction in RhoA activity in Cav1-/-MEFs. 24 At the same time, Src was linked to Cav1 phosphorylation and the phenotype of the MEFs, because the Y14F-Cav1 mutant could not restore cell polarity in the Cav1-/-cells. 24 Together, these data suggest that in fibroblasts Cav1 negatively regulates a Src-p190RhoGAP pathway to promote RhoA activity, while at the same time Src is required for Cav1 tyrosine phosphorylation and the induction of cell polarity. This apparent discrepancy may be resolved by the notion that only a few percent of the total cellular pool of Cav1 is tyrosine phosphorylated, and that this subfraction, once properly targeted to FAs, is sufficient to exert local regulatory functions. 24 By means of immunostainings for total, endogenous Cav1, our lab recently showed that, Rac1 activation induces the accumulation of Cav1 at FAs. 4 Since we could readily detect this, it is not likely to represent the few percent of cellular Cav1 that is Y14 phosphorylated. At the same time, Rac1 activation was not found to cause a significant induction of pY14Cav1. Yet Y14 phosphorylation is important, as we were unable to detect a Y14FCav1 mutant protein in FAs under conditions where normal Cav1 was readily detected at these sites. This may indicate that Y14 is part of a targeting motif that is disturbed by the Y14F mutation, or that the phosphorylation at Y14 is required for the initial targeting of Cav1 to FAs.
Results and Discussion
We studied the role of Cav1 tyrosine phosphorylation in more detail by using the Src inhibitor PP2 in Hela cells, stimulated with the Cytotoxic Necrotizing Factor1 (CNF1) to activate endogenous Rac1 (Fig. 1 ). In agreement with our previous observations, treatment of Hela cells with CNF1 induced an accumulation of Cav1 at paxillin-positive FAs (Fig 1) 4 . Src inhibition by PP2 (10μM) impaired the CNF1-induced accumulation of Cav1 at FAs, which shows that Src activity is required for the Rac1-driven FA-targeting of Cav1 (Fig 1) . To further investigate the involvement of Src, we next investigated Rac1-induced accumulation of Cav1 at FAs in mouse fibroblasts deficient for the Src family members SRC, YES and FYN (SYF-/-MEFs). Analysis of the subcellular localization showed that Q61LRac1 colocalizes with Paxillin in FAs (Fig 2A) . This indicates that Rac1 localizes upon 56 activation and independently of Src, to FAs. This is in marked contrast to Cav1, which did not accumulate at Rac1-associated FAs in the absence of Src kinases ( Fig   2B) . Finally, the requirement for Src to control Cav1 targeting is underscored by the observation that re-expression of Src restored Rac1-induced accumulation of Cav1
at FAs (Fig 2B) . 
The cooperative action of Rac1 with CDC42, which underlies the formation of focal complexes, has been suggested to drive the translocation of Src to these premature sites of adhesion. 25 Integrin-stimulated formation of FAs could therefore drive the recruitment and subsequent local activation of endosomal-associated Src in a RhoB-dependent fashion. Most recently, a role for the ESCRT (endosomal-sorting complexes required for transport) pathway in the targeting of active Src from late endosomes/lysosomes to FAs was described 40 . Intriguingly, the ESCRT pathway was also recently implicated in the sorting of ubiquitinated α5-integrin into multivesicular endosomes 41 . Thus, targeting to and from the endosomal compartment appears a key feature of (a subset of) FA proteins, which is important for FA turnover and thus for cell spreading and motility.
We recently showed by live-cell imaging using GFP-tagged Y14F-Cav1 that phosphorylation of Cav1 is not essential to target Cav1 towards the periphery of 58 the cell but is required to induce the translocation of Cav1 towards FAs. 4 (Fig 3) . In agreement with this observation, caveolar vesicles have recently been described to transiently interact with endosomes to exchange cargo by compartment-specific cues. 4, 42 As Src resides on endosomes, it would be of interest to determine whether Src and Cav1 already interact within the endosomal compartment, prior to targeting to FAs. These data suggest that phosphorylation of Y14Cav1 underlies Cav1 trafficking to FAs. However, we were not able to detect significant levels of pY14-phosphorylated Cav1 in cells expressing active Q61LRac1 or stimulated with CNF-1, conditions under which Cav1 accumulates at FAs. 4 This suggests that there is a considerable amount of non-phosphorylated Cav1 in FAs following integrinmediated adhesion, which could be generated by a FA-resident phosphatase, as also 59 indicated by the large number of tyrosine phosphatases identified in caveolae. 43 One such candidate phosphatase could be PTP1B, that negatively controls integrin signaling 44 and regulates both Src as well as phospho-Cav1 45, 46 . Based on the above arguments we here propose a model incorporating the Cav1 kinase Src and the potential role of the Cav1 Y14 event in the dynamics of FAs (Fig. 4) . Rac1-regulated endosomal traffic, likely in conjunction with microtubule dynamics and the ESCRT pathway, may play a key role in the Cav1
and Src recruitment, as well as in the consequent dissolution and turnover of FAs, which is an essential feature of cell motility.
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Material and Methods
Antibodies and DNA constructs. The following antibodies were used: anti-Paxillin (610619) and antiCav1 (610493) and these were both obtained from BD Bioscience, and anti-myc (13-2500) from Zymed. The Q61LRac1 construct was constructed as previously described 4 . Cell culture and transfection. Mouse fibroblasts and HeLa cells were maintained at 37ºC and 5% CO 2 in Iscove's Modified Dulbecco's Medium (IMDM; Biowhittaker) containing 10% heat-inactivated Fetal Calf Serum (Life Technologies, Breda, The Netherlands), 300 μg/ml glutamine, 100 units/ml penicillin and streptomycin. Cells were passaged by trypsinization. Cells were transiently transfected with FuGENE (Roche) or TransIT (Mirus) according to the manufacturers' recommendations. Immunofluorescence microscopy For immunostainings, cells were washed with ice-cold PBS, fixed with 3.7% paraformaldehyde for 20 min at RT and subsequently permeabilized with 1% triton, 10% glycerol in PBS for 3 min at RT. Cells were stained with the indicated antibodies, and confocal images were captured with a Zeiss 510 Meta laser-scanning confocal microscope and processed with LSM510 software.
